PATH | VRL
Menu

Preventing the Broad Spectrum of Perinatal Morbidity and Mortality Through Group B Streptococcal Vaccination

This article, published in Vaccine, presents the specific pregnancy-associated and neonatal conditions attributable, in part, to group B Streptococcus (GBS) in high- and lower-income countries. The authors provide a rationale for implementation of GBS glycoconjugate immunization during pregnancy to reduce the global burden of GBS-related morbidity and mortality in pregnant women and their infants. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Edwards MS, Gonik B

Published: 2013

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Edwards MS, Gonik B. Preventing the Broad Spectrum of Perinatal Morbidity and Mortality Through Group B Streptococcal Vaccination. Vaccine. 2013;31(Suppl 4):D66-D71. 

Resource types: Peer-reviewed journal

Diseases/vaccines: Group B Streptococcus (GBS)

Topics: Disease burden and surveillance, Disease/vaccine specific information

Regions: Global